Eric Benevich, Chief Commercial Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 11,256 shares at $89.62 ($1.0M) on 2021-08-16, disclosed to the SEC on 2021-08-18.
Open-market sale of $1.0M NBIX by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $89.62 | 5,628 | $504K | 50.0% |
| 2 | $89.62 | 5,628 | $504K | 50.0% |
| Total | $89.62 avg | 11,256 | $1.0M | 100% |
| Filing → |
| NBIX | SELL | 2025-02-14 | $503K | — | Filing → |
| NBIX | SELL | 2025-02-12 | $232K | — | Filing → |
| NBIX | SELL | 2025-02-04 | $369K | — | Filing → |